NF-κB does not modulate sensitivity of renal carcinoma cells to TNFα-related apoptosis-inducing ligand (TRAIL)

Anticancer Research

Volumn 20, Issue 6 B, 2000, Pages 4243-4255

  Pawlowski, J E ^a   Nesterov, A ^a   Scheinman, R I ^a   Johnson, T R ^a   Kraft, A S ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Apoptosis; cFLIP; NF B; TRAIL

Indexed keywords

CASPASE 8; CASPASE INHIBITOR; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY TEST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KIDNEY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, RENAL CELL; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASE 9; CASPASES; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY NEOPLASMS; LIGANDS; MAP KINASE KINASE 4; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034477093     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Identification and characterization of a new member of the TNF family that induces apoptosis
2. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
3. Safety and antitumor activity, of recombinant soluble Apo2 ligand
4. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD 4 T cell killing of target cells
5. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
6. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics
7. Tumoricidal activity, of tumor necrosis factor-related apoptosis-inducing ligand in vivo
8. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
9. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL
10. The receptor for the cytotoxic ligand TRAIL
11. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
12. Death receptor 5, a new member of the TNFR family and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway
13. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
14. A novel receptor for Apo2L/TRAIL contains a truncated death domain
15. The novel receptor TRAIL-R4 induces NFkappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
16. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha
17. The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage- inducible gene that is overexpressed in primary tumors of the gastrointestinal tract
18. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
19. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor- induced apoptosis
20. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA
21. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
22. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
23. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling
24. TRAIL: A molecule with multiple receptors and control mechanisms
25. Inhibition of death receptor signals by cellular FLIP
26. Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D
27. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE- inhibitory protein expression to TRAIL-induced apoptosis of melanoma
28. Tumor necrosis factor-related apoptosis- inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways
29. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
30. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB
31. Interleukin-2 in combination with interferon-alpha and 5- fluorouracil for metastatic renal cell cancer
32. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis- inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
33. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors
34. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
35. Molecular mechanism of basic calcium phosphate crystal-induced activation of human fibroblasts. Role of nuclear factor kappab, activator protein I and protein kinase c
36. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
37. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule
38. Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis
39. JNK/SAPK activity contributes to TRAIL-induced apoptosis
40. Apoptosis control by death and decoy receptors
41. Apoptosis signaling by death receptors
42. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
43. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
44. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration
45. Inhibition of proinflammatory molecule production by adenovirus- mediated expression of a nuclear factor kappaB superrepressor in human intestinal epithelial cells
46. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation
47. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation
48. TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways
49. Functional analysis of TRAIL receptors using monoclonal antibodies
50. The role of c-FLIP in modulation of CD95-induced apoptosis
51. Modulation of life and death by the TNF receptor superfamily
52. Multiple signals converging on NF-kappaB
53. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
54. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB
55. Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity
56. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells